Saxony Consortium Chooses Elsevier’s Leading Online Information Resources

Scopus and ScienceDirect enhance research experience at Saxony’s nine academic libraries

Amsterdam, 28th August 2006 – Elsevier today announced that the Saxony Consortium has signed a licensing agreement to provide Scopus® and ScienceDirect® to their users. The agreement ensures that all nine academic libraries in Saxony will provide more than ninety thousand students and researchers with access to the world’s most comprehensive and easy-to-use scientific, technical and medical (STM) information tools.

Scopus is the world’s largest abstract and citation database of research information and quality Web sources, while ScienceDirect provides users with access to over a quarter of the world’s full-text STM articles. Saxony’s students and researchers will now be able to seamlessly browse between the two resources.

“We chose Scopus and ScienceDirect for their breadth of scientific content, not only in our core research fields, but also in related disciplines such as engineering and other technical sciences”, said Karin Mittenzwei, library director of the Universitätsbibliothek "Georgius Agricola" der TU Bergakademie Freiberg. “We were also impressed with Scopus’ introduction of features such as Author Identifier and the Scopus Citation Tracker, which are powerful analytical tools for our users. And of course our students love them because both resources are intuitive and easy to use.”

“Colleges and universities within the Saxony Consortium rank among the pre-eminent research institutes in Europe and we are therefore honored to be selected to support their research workflows,” said Michael Neuroth, Country Sales Manager. “This license agreement proves that Scopus and ScienceDirect are both must-have resources in today’s most advanced and prestigious academic environments.”

Scopus has achieved tremendous worldwide acceptance since its launch in November 2004. Currently Scopus is playing a central role in the research workflow of scientists and students at universities in North and South America, Asia, Australia, Europe and the Middle East. Universities in the Saxony consortium will now join the growing number of academic institutes that have confirmed their commitment to Scopus.

The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2000 journals published by Elsevier and dynamic linking to journals from approximately 350 STM publishers through CrossRef. An expanding program of online major reference works, handbooks and book series in all fields of science seamlessly interlinks with primary research referenced in journal articles.


###

About Scopus
Covering the world’s research literature, Scopus is the largest and easiest to use navigation tool ever built. Scopus is designed and developed with over 300 users and librarians internationally. Its unique database contains abstracts and references from over 15,000 titles from 4,000 different publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also integrates web & patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool.
For more information about Scopus please visit www.info.scopus.com.

About ScienceDirect
Over a quarter of the world’s full text scientific, technical and medical (STM) articles – managed by renowned editors, written by respected authors and read by researchers from around the globe – are available in one place: ScienceDirect.

Elsevier’s extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over seven-and a half million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact:
Nick Ludlum
Fusion Public Relations
T: +1 202 661 4664
E: nickludlum@fusionpr.com